Screening of ~7000 coronavirus-specific compounds for anti-SARS-CoV-2 activity

doi:10.5281/zenodo.5838657

Published January 11, 2022 | Version v1

Dataset Open

Screening of ~7000 coronavirus-specific compounds for anti-SARS-CoV-2 activity

Van Damme, Ellen¹

1. Janssen Pharmaceutica NV

This short report describes the most relevant results of screening selected compounds with potential activity against SARS-CoV-2 in a VeroE6 cell-based anti-SARS-CoV-2 assay.

Files

Files (214.0 kB)

Name	Size	Download all
Screening of ~7000 coronavirus-specific compounds for anti-SARS-CoV-2 activity.xlsx md5:07445fe893610e8fe3324007f4744112	214.0 kB	Download

213

Views

Downloads

Show more details

	All versions	This version
Views	213	213
Downloads	13	13
Data volume	2.8 MB	2.8 MB

More info on how stats are collected....

DOI

Resource type

Dataset

Publisher

Zenodo

Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more

Technical metadata

Created: January 11, 2022
Modified: January 12, 2022

Screening of ~7000 coronavirus-specific compounds for anti-SARS-CoV-2 activity

Creators

Description

Files

Files (214.0 kB)